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Abstract
Background: The DNA-dependent protein kinase (DNA-PK) is a nuclear complex composed of a large catalytic
subunit (DNA-PKcs) and a heterodimeric DNA-targeting subunit Ku. DNA-PK is a major component of the non-
homologous end-joining (NHEJ) repair mechanism, which is activated in the presence of DNA double-strand breaks
induced by ionizing radiation, reactive oxygen species and radiomimetic drugs. We have recently reported that
down-regulation of protein kinase CK2 by siRNA interference results in enhanced cell death specifically in DNA-
PKcs-proficient human glioblastoma cells, and this event is accompanied by decreased autophosphorylation of
DNA-PKcs at S2056 and delayed repair of DNA double-strand breaks.
Results: In the present study, we show that CK2 co-localizes with phosphorylated histone H2AX to sites of DNA
damage and while CK2 gene knockdown is associated with delayed DNA damage repair, its overexpression
accelerates this process. We report for the first time evidence that lack of CK2 destabilizes the interaction of DNA-
PKcs with DNA and with Ku80 at sites of genetic lesions. Furthermore, we show that CK2 regulates the
phosphorylation levels of DNA-PKcs only in response to direct induction of DNA double-strand breaks.
Conclusions: Taken together, these results strongly indicate that CK2 plays a prominent role in NHEJ by facilitating
and/or stabilizing the binding of DNA-PKcs and, possibly other repair proteins, to the DNA ends contributing to
efficient DNA damage repair in mammalian cells.
Background
A wide variety of lesion types can affect the DNA
requiring the intervention of distinct and lesion-specific
DNA-repair mechanisms. However, it is known that
repair mechanisms may complement each other in some
respects by sharing many protein components [1]. DNA
double-strand breaks (DSBs) induced, for instance, by
ionizing radiation (IR) and radiomimetic drugs are diffi-
cult to repair and extremely toxic although they do not
occur as frequently as other types of DNA lesion [1,2].
DSBs are repaired by two main mechanisms: non-homo-
logous end-joining (NHEJ) and homologous recombina-
tion (HR). NHEJ is the major repair mechanism in
mammalian cells whereas HR is the predominant repair
mechanism in budding yeast [2]. In NHEJ, DNA lesions
are recognized by the Ku70/80 heterodimer. Localization
of Ku to sites of DSB serves to recruit other NHEJ pro-
teins such as the catalytic subunit of the DNA-depen-
dent protein kinase (DNA-PKcs), ligases and
polymerases [3,4]. The convergence of so many proteins
to sites of DNA lesion is thought to protect at first the
DNA ends from nucleases attack and later to facilitate
the repair process. DNA-PKcs is a Ser/Thr kinase char-
acterized by a weak activity that is significantly
enhanced in the presence of double-strand DNA and Ku
[4]. Modulation of its activity is not exclusively regulated
by the interaction with Ku on DNA ends. In this
respect, it has been reported that DNA-PKcs undergoes
autophosphorylation at multiple sites, which is followed
by DNA-PKcs release from DSBs in vivo and loss of
protein kinase activity in vitro [4]. The significance of
t h e s ee v e n t si sn o tf u l l yu n d e r s t o o d ,h o w e v e r ,i th a s
been suggested that autophosphorylation of DNA-PKcs
f a v o r sac o n f o r m a t i o n a lc h a n g et h a tm a ys e r v et o
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ends more accessible for damage-responsive proteins to
sites of DNA damage [5-7].
Protein kinase CK2 is an evolutionary highly con-
served Ser/Thr kinase composed of two catalytic subu-
nits a and/or a’ and two regulatory b-subunits [8,9].
CK2 is often described as a tetrameric enzyme but evi-
dence has suggested that the individual subunits do
not exist exclusively within the tetrameric complex but
also as free proteins [10-12]. CK2 is invariably elevated
in tumors and highly proliferating tissues and the de-
regulated expression of the catalytic subunits is causa-
tive of transformation especially in combination with
the altered expression of oncogenes and tumor sup-
pressor genes [13,14]. CK2 appears to be involved in a
plethora of cellular processes including regulation of
cell cycle progression, survival, proliferation and those
associated with various diseases, particularly cancer,
neurodegenerative- and inflammatory disorders [15,16].
Current data suggest that CK2 plays a role in DNA
sensing and repair. CK2 has been shown to phosphory-
late the scaffold protein XRCC1 thereby enabling the
assembly and activity of DNA single-strand breaks
repair at sites of chromosome breakage [17]. Moreover,
this kinase has been reported to phosphorylate the N-
terminal domain of the MDC1 adaptor protein
enabling its interaction with the NBS1 subunit of
MRN protein complex which is involved in the initial
processing of DNA repair [18,19]. Recently, by employ-
ing DNA-PKcs-proficient glioblastoma cells, we have
reported evidence that siRNA-mediated down-regula-
tion of the CK2 catalytic subunits results in significant
cell death, decreased DNA-PKcs autophosphorylation
at S2056 and delayed DNA repair following induction
of DSBs [20].
In this study, given the importance of DNA-PK in
DSBs repair, we have further elucidated the role of CK2
with respect to the molecular mechanisms activated in
response to DNA damage. We report for the first time
evidence that CK2 co-localizes with phospho-histone
H2AX (g-H2AX) to sites of DSB. We show that CK2
associates exclusively with DNA-PKcs and that the bind-
ing increases upon treatment of cells with radiomimetic
drugs. Furthermore, depletion of the CK2 catalytic subu-
nits destabilizes the interaction of DNA-PKcs with
Ku80, which indicates that the observed decreased
DNA-PKcs autophosphorylation might be the conse-
quence of lack of interaction between DNA-PKcs and
DNA on sites of genetic lesions.
Taken together, the reported observations strongly
suggest that CK2 is required for the NHEJ-dependent
cellular response to DSBs for an efficient repair process
by stabilizing NHEJ proteins at sites of DNA damage.
Methods
Cell culture
M059K, M059J, HCT116 and Cos-1 cell lines were cul-
tured in Dulbecco’s Modified Eagle’sM e d i u m( I n v i t r o -
gen, Denmark) supplemented with 10% FBS (Biochrom
AG, Germany). The H1299 cell line was cultured in
Roswell Park Memorial Institute medium (Invitrogen)
supplemented with 10% FBS. All cell lines were obtained
from the American Type Culture Collection (Rockville,
MD, USA) and maintained at 37°C under a 5% CO2
atmosphere.
Cell transfection and treatments
Cells were transfected with a set of four small interfering
RNA duplexes directed against CK2a and CK2a’ (ON-
TARGET plus SMARTpools, Dharmacon, CO, USA),
respectively, using Dharmafect I transfection reagent
(Dharmacon) for 72 hours according to the manufacturer’s
instructions. Where indicated, control experiments were
performed employing cells treated with transfection
reagent alone or in combination with scramble-siRNA
(Dharmacon). DNA damage was induced by cell treatment
with the radiomimetic drug NCS (0.5 μg/ml, a gift from
Dr. Hiroshi Maeda, Kumamoto University, Japan) and 33
μM Cisplatin (Sigma, Denmark), respectively, or exposure
to 20 J/m
2 UV irradiation (Stratalinker UV Crosslinker,
Stratagene, CA, USA) and 10 Gy ionizing radiation (6 MV
energy from an Elekta Synergy Accelerator, Elekta, Swe-
den), respectively. For transient overexpression of the indi-
cated proteins, cells were electroporated with the
corresponding expression plasmids by using the NEON™
Tranfection system (Invitrogen) according to the manufac-
turer’si n s t r u c t i o n s .
Plasmid constructs
The coding region of CK2a’ cloned into pcDNA3.1-
MycHis [21] was excised with HindIII/XhoI restriction
enzymes and inserted into pDsRed-Monomer N1 or
pEGFP-N1 (both from Clontech-Takara Bio Europe,
France), digested with HindIII/SalI, for the expression of
DsRed- and GFP-tagged CK2a’, respectively. The follow-
ing DNA-PKcs fragments: Fragment A (aa 515-830), Frag-
ment B (aa 1079-1533), Fragment C (aa 2005-2555),
Fragment D (aa 2768-3258) and Fragment E (aa 3414-
4123) were all cloned into the mammalian expression vec-
tor pcDNA3.1-MycHis (Invitrogen) using reverse tran-
scription PCR and total RNA extracted from HCT116
cells used as template. The following primer pairs were
employed: for fragment A, forward primer 5’-CGGGATC-
CACCATGGGAAGAACTGGCAAATGGAAGGTGC-3’
and reverse primer 5’-CGCTCGAGCACCACTTTAT-
TAAATCCTTTCTGG-3’; for fragment B, forward primer
5’-CGGGATCCACCATGGGATCGCTTGCCTTTAAT
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CAGGAGAAGACTCACAAGGCG-3’;f o rf r a g m e n tC ,
forward primer 5’-CGGGATCCACCATGGGAATC-
GAAATTAGGAAAGAAGCC-3’ and reverse primer 5’-
CGCTCGAGGGTATTTGAAGGTAACCTAG-3’;f o r
fragment D, forward primer 5’-CGGAATTCACCATGG-
GACAGGTCGTTCTGTACAG-3’ and reverse primer 5’-
CGCTCGAG TAGTTTCATAGCAAGTGAG-3’; for frag-
ment E, forward primer 5’-CGGAATTCACCATGG-
GAACGCTGGCAGATTTCTGTG-3’ and reverse primer
5’-CGCTCGAGTCCTTCCCAGGTTCTGCC-3’.P C R
products were inserted into BamHI-XhoI (Fragments A, B
and C) or EcoRI/XhoI (Fragments D and E) restriction
sites. The correctness of the sequences was verified by
DNA sequencing analysis of the cloned fragments.
Purification of recombinant proteins
Human recombinant CK2a was expressed and purified
essentially as described [22].
Clonogenic survival assay
M059K cells were transfected with siRNAs against
CK2a or CK2a’ and 48 hours after transfection, cells
were incubated with 0.5 μg/ml NCS for additional 24
hours. Afterwards, cells were trypsinized and seeded in
six-well plates and colonies were allowed to grow for 14
days. Subsequently, cells were washed once with PBS
and stained with a solution containing 6% glutaralde-
hyde/0.5% crystal violet and de-stained with tap water.
Colonies containing > 50 cells were quantified using the
UVIdoc software (Uvitec Ltd., UK).
Western blot analysis
Whole cell extracts and Western blots were as pre-
viously described [21,23]. The antibodies used were as
follows: mouse monoclonal anti-CK2a (#218703, Calbio-
chem, UK); mouse monoclonal anti-b-actin (#A3853,
Sigma); mouse monoclonal anti-DNA-PKcs, -Myc and
-Ku80 (#sc-5282, #sc-40, #sc-33653, all from Santa Cruz
Biotechnology, CA, USA); rabbit polyclonal anti-53BP1
(#4937, Cell Signaling Technology, MA, USA) and rab-
bit polyclonal anti-phospho-DNA-PKcs (p-S2056)
(#18192, Abcam, UK). Rabbit polyclonal anti-CK2a’ was
obtained by immunizing rabbits with a specific peptide
(SQPCADNAVLSSGTAAR) of human CK2a’. Rabbit
polyclonal anti-phospho-DNA-PKcs (p-T2609) and -(p-
T2647) were as described [23,24].
Immunoprecipitation assay
Experiments were performed essentially as described
previously [25] employing 1 mg cell lysate and monoclo-
nal anti-Myc (#2278, Cell Signaling Technology), rabbit
polyclonal anti-DNA-PKcs (#300-516A, Bethyl Labora-
tories, TX, USA) or anti-CK2a serum antibodies as
indicated in the figure legends. Anti-CK2a serum was
obtained by immunizing rabbits against the full-length
protein. 500 μg crude extracts from cells expressing var-
ious DNA-PKcs deletion mutants and 0.5 μg human
recombinant CK2a were employed in co-immunprecipi-
tation experiments for mapping the DNA-PKcs interac-
tion domains.
Immunofluorescence and in situ PLA
M059K cells grown on cover slips were incubated with
rabbit polyclonal anti-g-H2AX (p-S139) antibody (#2577,
Cell Signaling Technology, Denmark) followed by incu-
bation with biotinylated swine anti-rabbit IgG (Dako,
Denmark) and streptavidin-conjugated fluorescein-iso-
thiocyanate (Dako) as previously described [21]. Cells
were counterstained with 4’,6-diamidino-2-phenylindole
(DAPI) or Hoechst dye (Sigma), analyzed on a DMRBE
microscope (400× magnification) equipped with a Leica
DFC420C camera (Leica, Denmark) and processed using
ImageJ software (NIH, MD, USA). Threshold adjust-
ments were set to ensure quantification of true posi-
tively immunostained particles. For the analysis of g-
H2AX/CK2a’ interaction by in situ PLA, cells grown on
cover slips were incubated with mouse monoclonal anti-
g-H2AX (p-Ser139) antibody (#11174, Abcam) and a
rabbit polyclonal antibody against CK2a’.V i s u a l i z a t i o n
of protein-protein interaction was performed following
the manufacturer’s instructions (Olink Biosciences, Swe-
den) and as reported earlier (20). Similarly, interaction
between DNA-PKcs and Ku80 or histone H3 was ana-
lyzed labeling the cells with a mouse monoclonal anti-
body against DNA-PKcs and a rabbit polyclonal anti-
Ku80 antibody (#sc-5282, #sc-9034, both from Santa
Cruz Biotechnology) or a rabbit monoclonal anti-histone
H3 (#4499, Cell Signaling Technology). Interactions
between CK2a’/DNA-PKcs or CK2a’/Ku80 were ana-
lyzed using a rabbit polyclonal antibody against CK2a’
and a mouse monoclonal anti-Ku80 or anti-DNA-PKcs
antibodies (#sc-33653, #sc-9051, both from Santa Cruz
Biotechnology). The number of in situ proximity ligation
signals was determined using the freeware software
BlobFinder http://www.cb.uu.se/~amin/BlobFinder.
Statistical and densitometric analysis
The statistical significance of differences between means
of two groups was evaluated by the two-tailed t-test
(Student’s t-test). The levels of significance are indicated
in the figure legends.
Results
Down-regulation of CK2 significantly impairs cell survival
and results in persistent phosphorylation of histone H2AX
In order to investigate the role of CK2 in the cellular
response to DNA damage, human M059K glioblastoma
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RNAs (siRNAs) targeting the individual CK2 catalytic
subunits (i.e. si-CK2a and si-CK2a’, respectively) or
scramble-siRNA (si-Scr). Cells incubated in the absence
or presence of 0.5 μg/ml neocarzinostatin (NCS) for 24
hours were analyzed by staining with anti-g-H2AX anti-
body for the visualization of nuclear foci of DNA
damage [26,27]. The analysis revealed higher g-H2AX
signal in CK2a-a n d- a’-knockdown cells (i.e. ~30%)
with respect to cells treated with NCS alone or in com-
bination with scramble-siRNA transfection (Figure 1A
and 1B) indicative of impaired DNA damage signaling.
A clonogenic survival assay was subsequently performed
in order to test the survival ability of cells treated as
indicated in Figure 1C. Cells incubated with NCS and
transfected with scramble-siRNA displayed a 16-fold
lower survival rate in comparison to cells transfected
with scramble-siRNA alone. On the other hand, cells
exposed to NCS and transfected with siRNA against
CK2a or -a’ showed a 3-fold lower survival rate with
respect to cells transfected with scramble-siRNA and
incubated with NCS. Overall, results indicate that
CK2a-a n dC K 2 a’-knockdown cells display a similar
DNA damage response characterized by persistent g-
H2AX signal and lower cell survival rate in comparison
to cells transfected with scramble-siRNA and treated
with NCS.
CK2 is recruited to sites of DNA double-strand break
As down-regulation of the individual CK2 catalytic sub-
units resulted in impaired DNA damage signaling, we
investigated whether endogenous CK2 localizes to sites
o fD N Ad a m a g eb yl o o k i n ga tt h ea s s o c i a t i o nw i t hg-
H2AX. We performed in situ proximity ligation assay
(PLA), which enables the detection and quantification of
protein-protein interactions or proteins in close proxi-
mity in native cells [28]. As shown in Figure 2, double
staining of cells with antibodies directed against CK2a’
and g-H2AX, respectively, generated a significantly
higher number of fluorescent signals (i.e. about 130-
fold) in cells treated with NCS than in control- or
CK2a’-depleted cells indicating that endogenous CK2
co-localizes with g-H2AX to sites of DSB. To comple-
ment results described above, we examined whether the
overexpression of CK2 affected DNA repair mechanisms
induced by NCS treatment by looking at the dynamics
of g-H2AX in cells transiently expressing DsRed fluores-
cent protein (control experiment) or CK2a’-DsRed. As
s h o w ni nF i g u r e3 ,a na v e r a g eo f7 4g-H2AX foci per
cell were detected in cells expressing DsRed fluorescent
protein 1 hour after addition of 0.5 μg/ml NCS to the
incubation medium while cells expressing CK2a’-DsRed
showed an average of 67 foci per cell under the same
experimental conditions. After 4 hours from NCS
treatment, 51 foci per cell were detected in DsRed-
expressing cells while 14 foci per cell were still present
in CK2a’-DsRed-expressing cells. This suggests that
cells overexpressing CK2 display a prompt DNA damage
response with respect to cells expressing endogenous
levels of the kinase. We performed immunofluores-
cence-based experiments in order to clarify whether per-
sistent phosphorylation of histone H2AX in cells
depleted of CK2 and treated with NCS resulted from
impaired g-H2AX dephosphorylation or DNA repair
defect. Cells were labeled with antibodies directed
against p53 binding protein 1 (53BP1) which has been
shown to play a key role in DNA damage repair [29].
Interestingly, we found that silencing of CK2 did not
result in the persistence of 53BP1 foci as observed in
cells expressing CK2 and exposed to NCS. These results
suggest that persistent phosphorylation of histone
H2AX may result from CK2-mediated DNA repair
defect (Additional file 1: Figure S1).
Down-regulation of CK2 regulates DNA-PKcs
phosphorylation in response to DNA double-strand break
induction
Data reported above prompted us to investigate the
mode by which CK2 contributes to DSBs repair
mechanisms. We previously reported that down-regula-
tion of the individual CK2 catalytic subunits causes a
significant decrease in DNA-PKcs autophosphorylation
at Ser2056 in response to NCS treatment [20]. Here, we
extended the analysis of DNA-PKcs with respect to
other phosphorylation sites which were reported to be
rapidly phosphorylated in vivo upon exposure to ioniz-
ing radiation [30,31]. We obtained similar results with
respect to the phosphorylation status of DNA-PKcs in
cells transfected with scramble-siRNA or siRNAs against
the individual CK2 catalytic subunits and incubated with
either 0.5 μg/ml NCS for 1 hour (Figure 4A) or exposed
to 10 Gy of irradiation (1 hour recovery, Figure 4B).
The autophosphorylation of DNA-PKcs at Ser2056
decreased in CK2a-a n d- a’-knockdown cells, respec-
tively, following induction of DSBs as compared to con-
trol cells where only DNA damage was induced. DNA-
PKcs is phosphorylated at multiple sites within the so-
called Thr2609 cluster that is essential for efficient DSBs
repair [30]. As ATM (ataxia-telangiectasia mutated) has
been reported to phosphorylate DNA-PKcs within the
cluster [31], we looked at DNA-PKcs phosphorylation at
two conserved sites, i.e. Thr2609 and Thr2647, respec-
tively, that are likely to be relevant in vivo [3]. Western
blot analysis showed a response similar to that observed
i nt h ec a s eo fS e r 2 0 5 6p h o s p horylation in cells treated
with NCS (Figure 4A) or exposed to IR (Figure 4B).
However, the phosphorylation of Thr2609 did not
decrease in CK2-depleted cells exposed to 10 Gy of
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(Figure 4A). Additional experiments were performed
employing selective inhibitors of CK2 in order to
address the question as to whether the observed CK2-
mediated modulation of DNA-PKcs phosphorylation
was dependent on CK2 kinase activity. Results obtained
indicated that the kinase activity of CK2 does not regu-
late DNA-PKcs phosphorylation upon induction of
DNA damage (results not shown). In addition to IR
exposure, DNA-PKcs phosphorylation can be induced
upon treatment with agents (e.g. hydroxyurea, camp-
tothecin and cisplatin) or exposure to UV irradiation
that all together cause DNA replication block [5].
M059K cells incubated with 33 μM cisplatin or exposed
to 20 J/m
2 UV irradiation were subjected to a time-
course experiment in order to determine the contribu-
tion of CK2 to the modulation of DNA-PKcs phosphor-
ylation upon induction of replication-stress (Figure 4C).
Phosphorylation of DNA-PKcs at Ser2056, Thr2609 and
Thr2647 was markedly detected at 4-8 hours after UV
irradiation or cisplatin treatment. We compared the
phosphorylation status of DNA-PKcs in cells transfected
with scramble-siRNA or siRNAs against the individual
CK2 catalytic subunits and exposed to replication stress
for 8 hours. As shown in Figure 4D, cellular depletion
of CK2 did not significantly alter the phosphorylation of
DNA-PKcs induced under replication stress. Interest-
ingly, immunostaining of cells treated essentially as indi-
cated above with anti-g-H2AX did not result in changes
in the number of detected foci in cells expressing and
lacking CK2 expression, respectively, (Additional file 2:
Figure S2).
Next, in order to exclude the possibility that modula-
tion of DNA-PKcs phosphorylation by CK2 knockdown
expression was dependent on the particular cell line uti-
lized in the experiments, we analyzed the phosphoryla-
tion status of DNA-PKcs in lysates from human H1299
non-small cell lung carcinoma cells. As shown in Figure
Figure 1 Down-regulation of CK2 results in persistent g-H2AX
signal and reduced colony formation in human M059K
glioblastoma cells. A. Cells were transfected with scramble siRNA
(si-Scr), CK2a or -a’-siRNA for 72 hours. Where indicated, 0.5 μg/ml
neocarzinostatin (NCS) was added to the medium in the last 24
hours of incubation. Fixed cells were subsequently labeled with
anti-g-H2AX antibody and with a FITC-conjugated secondary
antibody. Nuclei were visualized by DAPI staining. B. Quantification
of g-H2AX-positive cells was performed by using ImageJ software
and expressed as percentage of the total number of cells in each
sample. Bars indicate mean values +/- standard deviation (SD) from
three independent experiments. *P < 0.0001 indicates statistically
significant difference in the number of g-H2AX-positive cells in CK2-
depleted versus si-Scr-treated cells. C. Cells were transfected with
CK2a-, -a’-siRNA or scramble siRNA for 72 hours. 0.5 μg/ml NCS was
added in the last hour of incubation. Control, refers to cell treated
with transfection reagent only. Cells were allowed to form clusters
for 14 days. Colonies were visualized by staining with crystal violet
as described in Experimental Procedures. Bar graph shows cell
colonies quantification. Average values +/- SD from three
independent experiments are shown relative to control (i.e.
transfection reagent-treated) cells. *P < 0.005 denotes statistically
significant difference in number of colonies formed as compared to
si-Scr-tranfected and NCS treated cells.
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with NCS resulted in marked DNA-PKcs autophosphor-
ylation at Ser2056 which was significantly reduced in
CK2a- and -a’-depleted cells, respectively, as in the case
of M059K glioblastoma cells. Phosphorylation of DNA-
PKcs at Thr2609 decreased slightly in CK2-depleted
cells exposed to NCS while no significant changes were
observed in cells left untreated or exposed to IR. As
observed in M059K cells exposed to UV irradiation or
treated with cisplatin, depletion of CK2 in H1299 cells
did not affect the phosphorylation levels of DNA-PKcs
with respect to control experi m e n t s .O v e r a l l ,r e s u l t s
reported here indicate that the ability of CK2 to modu-
late the phosphorylation of DNA-PKcs occurs specifi-
cally in response to direct induction of DSBs and it is
independent from the type of cells employed.
Figure 2 CK2 co-localizes with g-H2AX to sites of DNA damage. A. Association between CK2a’ and g-H2AX was revealed by in situ PLA. Cells
expressing or lacking CK2a’ were left untreated or incubated with 0.5 μg/ml NCS for 1 hour before fixation and labeling with primary antibodies
directed against the indicated proteins. Control, refers to cells transfected with si-CK2a’ and stained with secondary antibodies. Cell nuclei were
revealed by Hoechst staining. B. Quantification of the number of signals/cell as distinct fluorescent red spots was performed by computer-
assisted image analysis as described in Experimental Procedures. Mean values +/- SD from three independent experiments are shown. *P <
0.0001 denotes statistically significant difference.
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Ku80
Down-regulation of CK2 leads to decreased DNA-PKcs
autophosphorylation suggesting that CK2 either favors
the interaction between DNA-PKcs molecules for their
mutual phosphorylation in trans or mediates the asso-
ciation of DNA-PKcs with Ku in the presence of DNA.
As Chen et al., [5] demonstrated that the phosphoryla-
tion of DNA-PKcs at Ser2056 occurs directly between
two kinase molecules, we hypothesized that the
observed decreased autophosphorylation of DNA-PKcs
in CK2-depleted cells was caused by defective recruit-
ment of DNA-PKcs to sites of DNA damage. Therefore,
we examined whether the interaction between DNA-
PKcs and Ku80, whose expression levels do not vary in
cells depleted of CK2 [20], was affected in CK2-siRNA-
transfected cells. As shown in Figure 6A, immunopreci-
pitation experiments performed with an antibody direc-
ted against DNA-PKcs revealed a marked decrease in
DNA-PKcs/Ku80 association in cells depleted of CK2a/
a’. Similar results were obtained by performing in situ
PLA (Figure 6B and 6C) where we looked at the associa-
tion between DNA-PKcs and Ku80 directly in M059K
cells treated or not with NCS. Here, we reported a
~50% decrease in the number of fluorescent signals in
cells depleted of CK2 and exposed to NCS compared to
control experiment where cells were transfected with
scramble-siRNA and treated with NCS.
To address the question of whether CK2 interacts
with DNA-PKcs and/or Ku80, we used whole lysates
from HCT116 and M059K cells and performed co-
immunoprecipitation experiments employing antibodies
directed against CK2a. As shown in Figure 7A, CK2a/a’
co-immunoprecipitated with endogenous DNA-PKcs in
control cells and the association increased following
induction of DSBs by NCS treatment. However, we did
not detect any association with Ku80 protein (data not
shown). Moreover, the analysis of cells left untreated or
incubated with NCS did not show changes in the
expression levels of both proteins (results not shown).
In order to complement results obtained by co-immu-
noprecipitation experiments, we performed in situ PLA
employing M059K and M059J cells and looked at the
association between CK2a’ and either DNA-PKcs or
Ku80 in cells treated with NCS. As shown in Figure 7B
Figure 3 Cells overexpressing CK2 exhibit a prompt response
to induction of DNA double-strand break. A. M059K cells
transiently overexpressing CK2a’-DsRed or DsRed-fluorescent protein
were incubated with 0.5 μg/ml NCS for the indicated times.
Subsequently, cells were fixed and labeled with anti-g-H2AX
antibody. Cell nuclei were revealed by DAPI staining. Arrows: cells
overexpressing CK2a’-DsRed are more efficient in DNA damage
repair as compared to cells that do not overexpress the kinase. One
representative experiment is shown. B. Average g-H2AX foci number
per red fluorescent cell as described in A. Mean values +/- SD from
three independent experiments are shown. More than 100 cells
have been analyzed per experiment. *P < 0.001 denotes statistically
significant difference. NS, not significant.
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PKcs and CK2a’ in M059K cells as previously reported
[20]. As expected, a very low number of fluorescent sig-
nals was detected in M059J cells. Next, we looked at
fluorescent signals deriving from in situ PLA performed
employing antibodies directed against Ku80 and CK2a’,
respectively. Interestingly, the analysis of M059K cells
revealed an average of ~110 positive signals per cell but
this number was drastically reduced to ~20 positive sig-
nals per cell in M059J cells suggesting that CK2a’ does
not interact directly with Ku80. The evidence that CK2
interacts with DNA-PKcs, prompted us to define the
DNA-PKcs-region(s) responsible for the interaction with
CK2. Interaction studies were performed with human
recombinant CK2a and a panel of Myc-tagged DNA-
PKcs deletion fragments covering extensively the amino
acid sequence of DNA-PKcs and transiently expressed
in Cos-1 cells (Figure 7D and 7E). Experiments of co-
immunoprecipitation performed employing anti-Myc
antibody, revealed that two DNA-PKcs fragments, i.e.
Figure 4 CK2 depletion results in decreased DNA-PKcs phosphorylation in M059K cells following induction of DNA double-strand
break. A. Cells were treated as described in Figure 1. Whole cell extracts were employed for Western blot analysis of the indicated proteins.
Detection of b-actin was used as loading control. B. Cells were treated essentially as described in Figure 1 except that DNA damage was
induced by cell exposure to 10 Gy ionizing radiation. After 1 hour, cells were harvested and total cell lysates were prepared for Western blot
analysis. C. M059K cells were treated with 33 μM cisplatin (cisPt) or exposed to 20 J/m
2 UV irradiation for the indicated time-points. Cell extract
from control and treated cells was prepared and analyzed by Western blot employing antibodies against DNA-PKcs or its phosphorylated forms
as indicated in the figure. D. Experiments were performed as described above and in Figure 1 except that cells were treated with cisPt (33 μM, 8
hours incubation) or exposed to UV (20 J/m
2, 8 hours recovery) as indicated in the figure. Whole cell lysates were prepared for the analysis by
Western blot of DNA-PKcs phosphorylation at S2056, T2609 and T2647. Experiments were performed at least three times obtaining similar results.
Data from one representative experiment are shown.
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2005-2555 and 2768-3258, respectively, interact specifi-
cally with CK2a (Figure 7E). Analysis of protein
sequences preceding fragment A as Myc-fusions has not
been possible due to difficulties in expressing N-term-
inal fragments.
Discussion
NHEJ is the predominant repair pathway in mammalian
cells that is activated in the presence of DSBs and
requires the intervention of the DNA-PK complex for
an adequate damage response. Although the importance
of DNA-PKcs in DSB repair is well established and has
been extensively studied, the precise mechanism by
which this enzyme localizes to sites of DSB, phosphory-
lates itself and other repair proteins to promote NHEJ is
still elusive. In this study, we report evidence that pro-
tein kinase CK2 contributes significantly to the DNA-
PKcs-mediated cellular response to DNA damage. Lack
of CK2 leads to marked cell death, persistent DNA
damage and reduced survival rate in cells treated with
radiomimetic drugs. We show that endogenous CK2 co-
localizes with g-H2AX to sites of DNA damage and its
overexpression results in rapid decrease in the number
of detected nuclear foci. This suggests that CK2 plays
an important role in the DNA damage response. Experi-
ments of co-immunoprecipitation and in situ PLA led
to the observation that lack of CK2 destabilizes the
Ku80/DNA-PKcs complex formation. These findings
might explain the delayed DNA repair observed in cells
lacking CK2 and, because survival of cells exposed to
genotoxic stress is largely dependent on efficient repair
of DSBs, the low clonogenic survival observed in CK2-
depleted cells. The reported lack of association between
Ku80 and DNA-PKcs in CK2-knockdown cells sug-
gested that CK2 might mediate their interaction. How-
ever, we showed that endogenous CK2 binds to DNA-
PKcs and the association is enhanced in response to
DNA damage but we could not detect the presence of
Ku80 in the complex formation. This has led to the
hypothesis that CK2 interacts exclusively with DNA-
PKcs facilitating and/or stabilizing the binding of the
latter to DNA which has been reported to be weak [32].
In support of this notion, results obtained by in situ
PLA where the binding of DNA-PK to chromatin com-
ponents (i.e. histone H3) was tested in cells exposed to
NCS, show that the association between DNA-PKcs and
histone H3 is attenuated in cells lacking CK2 (Addi-
tional file 3: Figure S3). Data derived from the co-immu-
noprecipitation experiments and in situ PLA (Figure 7)
suggest that CK2 binds exclusively DNA-PK. In this
respect, the high level of fluorescent signal detected in
M059K cells, which would indicate that CK2a’ is also
associated with Ku80, is almost completely suppressed
in DNA-PKcs-deficient M059J cells. The association
between CK2 and DNA-PKcs does not seem to be
strictly dependent upon DSBs induction since we
detected association also in the absence of DNA damage
although to a lesser extent. This has been previously
reported in interaction studies between mediator of
DNA damage checkpoint protein 1 (MDC1) and NBS1
subunit of MRN comlex [18,19]. Here, the authors
showed that the CK2-mediated phosphorylation of the
STD-repeats of MDC1 enhances the binding to NBS1
thereby promoting the local concentration and/or stabi-
lity of DNA damage regulators at sites of genetic lesions.
MDC1 has also been shown to regulate DNA-PK autop-
hosphorylation [33]. Our studies [20] indicate that it is
Figure 5 Decreased phosphorylation of DNA-PKcs in CK2-depleted cells is not confined solely to glioblastoma cells. The human non-
small cell lung carcinoma H1299 cell line was subjected to treatments described in Figures 1 and 5. Western blot analysis of whole cell lysate
was performed employing antibodies against proteins indicated in the figure. Experiments were performed three times obtaining similar results
and data from one representative experiment are shown.
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Page 9 of 13not the catalytic activity of CK2 but rather the protein
itself that regulates the interaction of DNA-PKcs with
DNA at sites of damage underlining the multiplicity of
the effects exerted by CK2. In light of the fact that CK2
might facilitate the binding of DNA-PKcs to DNA upon
induction of DSBs, we believe that the apparent low
phosphorylation levels of DNA-PKcs at S2056, T2609
and T2647 in CK2-depleted cells (Figures 4 and 5)
might be caused by defective recruitment of DNA-PKcs
to sites of DNA damage.
DNA-PKcs phosphorylation at T2609 in cells lacking
CK2a or -a’ and exposed to ionizing radiation did not
lead to results similar to those obtained with cells trea-
ted with NCS (Figure 4). Currently, the reason for this
discrepancy is not clear as both types of treatment
generate DSB. However, T2609 is reported to be phos-
phorylated by all three members of the phosphoinosi-
tide 3-kinase-like family of protein kinases (PIKKs) and
possibly other kinases [4], whose kinetic of phosphoryla-
tion might be differently regulated upon exposure of
cells to IR or treatment with radiomimetic drugs. How-
ever, one cannot exclude that lack of chromatin remo-
deling may occur in CK2 deficient cells and lead to
defective DNA-PK phosphorylation and other effects. In
this respect, it has been shown that CK2 is implicated
in chromatin remodeling by controlling the mobilization
of HP1-beta through modulation of its phosphorylation
at Thr51 [34].
Through experiments of mapping protein-protein
interactions in vitro we defined two regions in DNA-
PKcs responsible for the association with CK2a com-
prised between amino acid residues 2005-2555 (frag-
ment C) and 2768-3258 (fragment D). It is conceivable
that amino acids between these two regions which com-
prise the so-called ABCDE cluster of in vivo phosphory-
lation sites [35,36] are also involved in the interaction
with CK2. It remains to be addressed whether the phos-
phorylation of these amino acids are affected upon bind-
ing of CK2 to DNA-PKcs. Fragment D comprises part of
the so-called FAT domain, which is conserved in PIKKs
Figure 6 siRNA-mediated knock-down of CK2 destabilizes the
association between DNA-PKcs and Ku80. A. Cells were
transfected with si-Scr and si-CK2a/a’, respectively. After 71 hours,
cells were incubated with 0.5 μg/ml NCS for 1 additional hour as
indicated in the figure. Whole cell lysate was subjected to co-
immunoprecipitation (IP) with a rabbit polyclonal anti-DNA-PKcs
antibody. Immunoprecipitated proteins were revealed by Western
blot employing mouse monoclonal antibodies against the indicated
proteins. A control experiment was performed where crude extract
from cells transfected with scramble-siRNA was subjected to
immunoprecipitation with normal rabbit serum (-). B. In situ
association between DNA-PKcs and Ku80 was investigated in
M059K- and DNA-PKcs-deficient M059J cells, treated according to
conditions indicated in the figure, by in situ PLA. The molecular
interaction is indicated by the presence of distinct red fluorescent
spots in the cell nuclei. C. Quantification of the number of positive
signals/cell was performed by computer-assisted image analysis.
Mean values +/- SD from three independent experiments are
shown. *P < 0.0001 denotes statistically significant difference
between cell populations incubated with 0.5 μg/ml NCS for 1 hour
and treated with si-Scr or siRNAs against CK2a and -a’, respectively.
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Page 10 of 13Figure 7 DNA-PKcs associates with CK2. The complex formation is enhanced upon induction of DNA damage. A.C e l ll y s a t e sf r o m
HCT116 and M059K cells were employed in co-immunoprecipitation experiments in the presence of normal rabbit serum (-) or rabbit polyclonal
anti-CK2a antibody. Immunoprecipitates were analyzed by Western blot with antibodies against the indicated proteins. B. The association
between endogenous CK2a’ and DNA-PKcs or Ku80 were explored by in situ PLA in M059K cells treated with 0.5 μg/ml NCS for 1 hour. Control
experiments were performed employing either M059J- or M059K cells depleted of CK2a’ as indicated in the figure. TR, transfection reagent. C.
Quantification of number of positive signals/cell was performed as reported in Figure 2. Average values +/- SD from three independent
experiments are shown. *P < 0.0001 denotes statistically significant differences between values obtained with M059K- and M059J cells,
respectively, in the two assays. D. Schematic representation of DNA-PKcs linear sequence with some of the major domains indicated. LRR,
leucine-rich region; PQR and ABCDE, clusters of phosphorylation sites; FAT, FRAP-ATM-TRRAP domain at the C-terminus; catalytic; PI3K- catalytic
domain. The DNA-PKcs fragments employed in the study generated with a C-terminal Myc-tag are indicated below the bar. E. Whole extracts
(500 μg) from Cos-1 cells expressing various DNA-PKcs deletion mutants (fragments A-E) were incubated with 0.5 μg purified human
recombinant CK2a in the presence of either rabbit serum (-) or a rabbit monoclonal anti-Myc antibody. Precipitates were analyzed by Western
blot employing mouse monoclonal antibodies directed against CK2a and Myc, respectively. EV indicates whole extract from cells transfected
with empty vector and subjected to immunoprecipitation in the presence of recombinant CK2a (control experiment). *, denotes an unspecific
protein band.
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Page 11 of 13and seems to regulate PIKKs kinase activity [37]. Part of
the FAT domain comprises a high-affinity Ku binding
(aa 3400-3420). Fragment E includes part of this Ku
binding sequence. However, no interaction was found
with CK2 suggesting that the association of DNA-PKcs
with Ku and CK2, respectively, involves different
domains.
Conclusions
In summary, we show for the first time that protein
kinase CK2 co-localizes with g-H2AX to sites of genetic
lesions and modulation of its expression levels affects
the cellular DNA damage response. CK2 interacts with
DNA-PKcs in mammalian cells in the absence of DNA
damage and the association increases upon cell treat-
ment with radiomimetic drugs. In vitro studies employ-
ing a panel of DNA-PKcs fragments and human
recombinant CK2a show that the interaction is direct
although one cannot exclude that the complex forma-
tion between CK2 and native, full length DNA-PKcs
might occur in the presence of other DNA repair pro-
teins and DNA. Evidence suggests that CK2 might facili-
tate and/or stabilize the binding of DNA-PKcs and
possibly other proteins of NHEJ, to DNA ends contri-
buting to efficient DNA damage repair. Additional
experiments are necessary to further dissect the molecu-
lar mechanisms involved in NHEJ, nevertheless, the pre-
sent findings point to CK2 as a prominent novel
signaling kinase regulating DNA-PKcs fate in cells
exposed to ionizing radiation or radiomimetic drugs.
Additional material
Additional file 1: Figure S1. 53BP1 focus formation in cells treated
with NCS. Cells were transfected with scramble siRNA (si-Scr), CK2a or
-a’-siRNA for 72 hours. Where indicated, 0.5 μg/ml neocarzinostatin (NCS)
was added to the medium in the last 24 hours of incubation. Fixed cells
were subsequently labeled with anti-53BP1 antibody and with a FITC-
conjugated secondary antibody. Nuclei were visualized by DAPI staining.
Additional file 2: Figure S2. g-H2AX focus formation in cells treated
with cisPT or exposed to UV irradiation. Cells were treated essentially
as described in Figure 4D. After treatment, fixed cells were stained with
anti-g-H2AX and subsequently with a FITC-conjugated secondary
antibody for revealing the presence of foci of DNA damage. Nuclei were
visualized by DAPI staining.
Additional file 3: Figure S3. in situ PLA reveals interaction between
DNA-PK and histone H3 in cells treated with NCS and expressing
CK2. A. Association between DNA-PKcs and histone H3 was investigated
by in situ PLA in M059K cells treated as indicated in the figure and
exposed to 0.5 μg/ml NCS for 1 hour. The molecular interaction is
indicated by the presence of distinct red fluorescent spots in the cell
nuclei. Control indicates cells treated with si-Scr and NCS and stained
with the secondary antibodies after fixation. B. Quantification of the
number of positive signals/cell was performed by computer-assisted
image analysis. Mean values +/- SD from three independent experiments
are shown. *P < 0.0001 denotes statistically significant difference
between cell populations treated with si-Scr and siRNAs against CK2a’,
respectively.
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